The anti-inflammatory and analgesic potential of the probiotic Streptococcus thermophilus via inhibition of endocannabinoid-degrading enzymes: a preliminary in vitro study

Abstract

Aim:The benefit of topical application of probiotics on pain and itching associated with skin disorders has become an increasingly intriguing topic in recent years. These effects are mainly associated with the anti-inflammatory activity of probiotics. Given the crucial role of the endocannabinoid system (ECS) in skin pathophysiology, here, the ability of Streptococcus thermophilus was evaluated, in comparison with Lactobacillus acidophilus, to inhibit two enzymes involved in endocannabinoid (eCB) degradation: fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).

Methods:Bacterial lysates were obtained from both probiotics. FAAH and MAGL activities were assayed using fluorometric and colorimetric methods. The effect of probiotic lysates on FAAH and MAGL activities was also evaluated on human keratinocytes stimulated with lipopolysaccharide (LPS).

Results: S. thermophilus inhibited both FAAH and MAGL, although to varying extents. In comparison,L. acidophilus had a minimal effect on FAAH and did not influence MAGL activity.

Conclusions:Although preliminary, our findings suggest that S. thermophilus may exert both potential analgesic and anti-inflammatory effects by modulating the ECS and reducing the degradation of EC, known to play a key role in immune regulation and inflammation. Results presented confirm the selective actions of probiotics and propose a novel mechanism that may contribute to the beneficial effects ofS. thermophilus in alleviating signs and symptoms associated with inflammatory skin conditions. Our evidence shows significant inhibitory activity of S. thermophilus on FAAH and MAGL activity, suggesting its ability to influence skin conditions by modulating ECS and preventing the eCB degradation.

Keywords

probiotics / Streptococcus thermophilus / pain / endocannabinoids / fatty acid amide hydrolase (FAAH) / monoacylglycerol lipase (MAGL) / human keratinocytes

References

[1] Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11: 506-14.

[2] Altamura S, Pietropaoli D, Lombardi F, Pinto RD, Ferri C. An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease. Biomedicines. 2023; 11: 3033.

[3] Sepehr A, Miri ST, Aghamohammad S, Rahimirad N, Milani M, Pourshafie M, et al. Health benefits, antimicrobial activities, and potential applications of probiotics: A review. Medicine (Baltimore). 2024; 103: e32412.

[4] Altamura S, Lombardi F, Augello FR, Barone A, Giannoni M, Cinque B, et al. Levilactobacillus brevis CD2 as a multifaceted probiotic to preserve oral health: results of a double-blind, randomized, placebo-controlled trial in healthy adults . J Transl Med. 2025; 23: 128.

[5] Bhatia A, Sharma D, Mehta J, Kumarasamy V, Begum MY, Siddiqua A, et al. Probiotics and Synbiotics: Applications, Benefits, and Mechanisms for the Improvement of Human and Ecological Health. J Multidiscip Healthc. 2025; 18: 1493-510.

[6] Cho M, Eom J, Choi E, Yang S, Lee D, Kim YY, et al. Recent advances in therapeutic probiotics: insights from human trials. Clin Microbiol Rev. 2025; 38: e0024024.

[7] Altamura S, Augello FR, Lombardi F, Palumbo P, Cinque B, Pietropaoli D, et al. In Vitro, Ex Vivo, and In Vivo Evidence of Nitrate-Reducing Activity in Levilactobacillus brevis CD2: A Potential Tool for Oral and Systemic Health Applications . Foods. 2025; 14: 1512.

[8] Marzio LD, Centi C, Cinque B, Masci S, Giuliani M, Arcieri A, et al. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients . Exp Dermatol. 2003; 12: 615-20.

[9] Gueniche A, Knaudt B, Schuck E, Volz T, Bastien P, Martin R, et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study . Br J Dermatol. 2008; 159: 1357-63.

[10] Rather IA, Bajpai VK, Kumar S, Lim J, Paek WK, Park Y. Probiotics and Atopic Dermatitis: An Overview. Front Microbiol. 2016; 7: 507.

[11] Blanchet-Réthoré S, Bourdès V, Mercenier A, Haddar CH, Verhoeven PO, Andres P. Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on Staphylococcus aureus colonization in atopic dermatitis . Clin Cosmet Investig Dermatol. 2017; 10: 249-57.

[12] Goodarzi A, Mozafarpoor S, Bodaghabadi M, Mohamadi M. The potential of probiotics for treating acne vulgaris: A review of literature on acne and microbiota. Dermatol Ther. 2020; 33: e13279.

[13] Bakhshandi AK, Minasazi A, Yeganeh O, Behi M. Therapeutic potential of microbiota modulation in psoriasis: current evidence and future directions. Arch Dermatol Res. 2025; 317: 561.

[14] Augello FR, Lombardi F, Ciafarone A, Altamura S, Marazzato M, Artone S, et al. Streptococcus thermophilus CNCM I-5570 lysate counteracts the aging process in human dermal fibroblast cells by neutralizing harmful free radicals and impacting antioxidant and anti-inflammatory pathways, thus restoring their physiological functions . Biomed Pharmacother. 2025; 185: 117975.

[15] Lombardi F, Palumbo P, Mattei A, Augello FR, Cifone MG, Giuliani M, et al. Soluble Fraction from Lysates of Selected Probiotic Strains Differently Influences Re-Epithelialization of HaCaT Scratched Monolayer through a Mechanism Involving Nitric Oxide Synthase 2. Biomolecules. 2019; 9: 756.

[16] Lombardi F, Augello FR, Artone S, Bahiti B, Sheldon JM, Giuliani M, et al. Efficacy of probiotic Streptococcus thermophilus in counteracting TGF-β1-induced fibrotic response in normal human dermal fibroblasts . J Inflamm (Lond). 2022; 19: 27.

[17] Zoccali G, Cinque B, Torre CL, Lombardi F, Palumbo P, Romano L, et al. Improving the outcome of fractional CO₂ laser resurfacing using a probiotic skin cream: Preliminary clinical evaluation . Lasers Med Sci. 2016; 31: 1607-11.

[18] Di Marzio L, Cinque B, Cupelli F, De Simone C, Cifone MG, Giuliani M. Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus . Int J Immunopathol Pharmacol. 2008; 21: 137-43.

[19] Di Marzio L, Cinque B, De Simone C, Cifone MG. Effect of the lactic acid bacterium Streptococcus thermophilus on ceramide levels in human keratinocytes in vitro and stratum corneum in vivo . J Invest Dermatol. 1999; 113: 98-106.

[20] Knackstedt R, Knackstedt T, Gatherwright J. The role of topical probiotics in skin conditions: A systematic review of animal and human studies and implications for future therapies. Exp Dermatol. 2020; 29: 15-21.

[21] Ambrożej D, Kunkiel K, Dumycz K, Feleszko W. The use of probiotics and bacteria-derived preparations in topical treatment of atopic dermatitis-A systematic review. J Allergy Clin Immunol Pract. 2021; 9: 570-5.e2.

[22] Gao T, Wang X, Li Y, Ren F. The Role of Probiotics in Skin Health and Related Gut-Skin Axis: A Review. Nutrients. 2023; 15: 3123.

[23] Guéniche A, Hennino A, Goujon C, Dahel K, Bastien P, Martin R, et al. Improvement of atopic dermatitis skin symptoms by Vitreoscilla filiformis bacterial extract . Eur J Dermatol. 2006; 16: 380-4.

[24] Volz T, Skabytska Y, Guenova E, Chen K, Frick J, Kirschning CJ, et al. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J Invest Dermatol. 2014; 134: 96-104.

[25] Park SB, Im M, Lee Y, Lee JH, Lim J, Park Y, et al. Effect of emollients containing vegetable-derived lactobacillus in the treatment of atopic dermatitis symptoms: split-body clinical trial. Ann Dermatol. 2014; 26: 150-5.

[26] Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor MB, Garaiova I, et al. Probiotics in the prevention of eczema: a randomised controlled trial. Arch Dis Child. 2014; 99: 1014-9.

[27] Holz C, Benning J, Schaudt M, Heilmann A, Schultchen J, Goelling D, et al. Novel bioactive from Lactobacillus brevis DSM17250 to stimulate the growth of Staphylococcus epidermidis: a pilot study . Benef Microbes. 2017; 8: 121-31.

[28] Reygagne P, Bastien P, Couavoux MP, Philippe D, Renouf M, Castiel-Higounenc I, et al. The positive benefit of Lactobacillus paracasei NCC2461 ST11 in healthy volunteers with moderate to severe dandruff . Benef Microbes. 2017; 8: 671-80.

[29] Khmaladze I, Butler E, Fabre S, Gillbro JM. Lactobacillus reuteri DSM 17938-A comparative study on the effect of probiotics and lysates on human skin . Exp Dermatol. 2019; 28: 822-8.

[30] Knackstedt R, Knackstedt T, Gatherwright J. The role of topical probiotics on wound healing: A review of animal and human studies. Int Wound J. 2020; 17: 1687-94.

[31] Herman A, Herman AP. Antimicrobial peptides activity in the skin. Skin Res Technol. 2019; 25: 111-7.

[32] Maccarrone M, Bab I, Bíró T, Cabral GA, Dey SK, Marzo VD, et al. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci. 2015; 36: 277-96.

[33] Río CD, Millán E, García V, Appendino G, DeMesa J, Muñoz E. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. Biochem Pharmacol. 2018; 157: 122-33.

[34] Osafo N, Yeboah OK, Antwi AO. Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation. Mol Biol Rep. 2021; 48: 3665-80.

[35] Maccarrone M, Di Marzo V, Gertsch J, Grether U, Howlett AC, Hua T, et al. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years. Pharmacol Rev. 2023; 75: 885-958.

[36] Yoo EH, Lee JH. Cannabinoids and Their Receptors in Skin Diseases. Int J Mol Sci. 2023; 24: 16523.

[37] Böhm M, Stegemann A, Paus R, Kleszczyński K, Maity P, Wlaschek M, et al. Endocrine Controls of Skin Aging. Endocr Rev. 2025; 46: 349-75.

[38] Tóth KF, Ádám D, Bíró T, Oláh A. Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System. Molecules. 2019; 24: 918.

[39] Oláh A, Alam M, Chéret J, Kis NG, Hegyi Z, Szöllősi AG, et al. Mitochondrial energy metabolism is negatively regulated by cannabinoid receptor 1 in intact human epidermis. Exp Dermatol. 2020; 29: 616-22.

[40] Correia-Sá IB, Carvalho CM, Serrão PV, Loureiro AI, Fernandes-Lopes C, Marques M, et al. A new role for anandamide: defective link between the systemic and skin endocannabinoid systems in hypertrophic human wound healing. Sci Rep. 2020; 10: 11134.

[41] Casanova ML, Blázquez C, Martínez-Palacio J, Villanueva C, Fernández-Aceñero MJ, Huffman JW, et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest. 2003; 111: 43-50.

[42] Blázquez C, Carracedo A, Barrado L, Real PJ, Fernández-Luna JL, Velasco G, et al. Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J. 2006; 20: 2633-5.

[43] Iden JA, Raphael-Mizrahi B, Naim A, Kolomansky A, Liron T, Neumann D, et al. The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer. Int J Mol Sci. 2023; 24: 7773.

[44] Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 1996; 384: 83-7.

[45] Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A. 2002; 99: 10819-24.

[46] Lombardi F, Augello FR, Palumbo P, Bonfili L, Artone S, Altamura S, et al. Bacterial Lysate from the Multi-Strain Probiotic SLAB51 Triggers Adaptative Responses to Hypoxia in Human Caco-2 Intestinal Epithelial Cells under Normoxic Conditions and Attenuates LPS-Induced Inflammatory Response. Int J Mol Sci. 2023; 24: 8134.

[47] Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, et al. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci U S A. 2009; 106: 20270-5.

[48] Tortolani D, Di Meo C, Standoli S, Ciaramellano F, Kadhim S, Hsu E, et al. Rare Phytocannabinoids Exert Anti-Inflammatory Effects on Human Keratinocytes via the Endocannabinoid System and MAPK Signaling Pathway. Int J Mol Sci. 2023; 24: 2721.

[49] Di Meo C, Tortolani D, Standoli S, Ciaramellano F, Angelucci BC, Tisi A, et al. Cannabinol modulates the endocannabinoid system and shows TRPV1-mediated anti-inflammatory properties in human keratinocytes. Biofactors. 2025; 51: e2122.

[50] Ashraf R, Shah NP. Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr. 2014; 54: 938-56.

[51] Hevia A, Delgado S, Sánchez B, Margolles A. Molecular Players Involved in the Interaction Between Beneficial Bacteria and the Immune System. Front Microbiol. 2015; 6: 1285.

[52] Mazziotta C, Tognon M, Martini F, Torreggiani E, Rotondo JC. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells. 2023; 12: 184.

[53] Thoda C, Touraki M. Immunomodulatory Properties of Probiotics and Their Derived Bioactive Compounds. Applied Sciences. 2023; 13: 4726.

[54] Suryavanshi SV, Kovalchuk I, Kovalchuk O. Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective. Front Immunol. 2021; 11: 613613.

[55] Yong TL, Zaman R, Rehman N, Tan CK. Ceramides and Skin Health: New Insights. Exp Dermatol. 2025; 34: e70042.

[56] Sakai T, Hatano Y. Stratum corneum pH and ceramides: Key regulators and biomarkers of skin barrier function in atopic dermatitis. J Dermatol Sci. 2025; 118: 51-7.

[57] de Aragon CAJ, Berna-Rico E, Prieto L, Abarquero-Cerezo M, Gonzalez-Cantero A. Improving the quality of life of patients with inflammatory skin diseases: a multicenter evaluation of a ceramide-containing regimen in patients with atopic dermatitis, psoriasis and xerosis. J Dermatolog Treat. 2025; 36: 2486702.

[58] Turcotte C, Blanchet M, Laviolette M, Flamand N. The CB₂ receptor and its role as a regulator of inflammation . Cell Mol Life Sci. 2016; 73: 4449-70.

[59] Rakotoarivelo V, Mayer TZ, Simard M, Flamand N, Di Marzo V. The Impact of the CB₂ Cannabinoid Receptor in Inflammatory Diseases: An Update . Molecules. 2024; 29: 3381.

[60] Petrosino S, Verde R, Vaia M, Allarà M, Iuvone T, Marzo VD. Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis. J Pharmacol Exp Ther. 2018; 365: 652-63.

[61] Martinelli G, Magnavacca A, Fumagalli M, DellʼAgli M, Piazza S, Sangiovanni E. Cannabis sativa and Skin Health: Dissecting the Role of Phytocannabinoids . Planta Med. 2022; 88: 492-506.

[62] Martins AM, Gomes AL, Boas IV, Marto J, Ribeiro HM. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals (Basel). 2022; 15: 210.

[63] Fumagalli M, Martinelli G, Paladino G, Rossini N, Ciriello U, Nicolaci V, et al. Beyond Cannabidiol: The Contribution of Cannabis sativa Phytocomplex to Skin Anti-Inflammatory Activity in Human Skin Keratinocytes . Pharmaceuticals (Basel). 2025; 18: 647.

[64] Di Scala C, Mazzarino M, Yahi N, Varini K, Garmy N, Fantini J, et al. Anandamide-ceramide interactions in a membrane environment: Molecular dynamic simulations data. Data Brief. 2017; 14: 163-7.

[65] Di Scala C, Fantini J, Yahi N, Barrantes FJ, Chahinian H. Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter. Biomolecules. 2018; 8: 31.

[66] Di Scala C, Mazzarino M, Yahi N, Varini K, Garmy N, Fantini J, et al. Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in human neuroblastoma cells. Chem Phys Lipids. 2017; 205: 11-7.

[67] Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, et al. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci. 2010; 13: 1113-9.

[68] Van Esbroeck ACM, Janssen APA, Cognetta III AB, Ogasawara D, Shpak G, Van der Kroeg M, et al. Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474. Science. 2017; 356: 1084-7.

[69] Lombardi F, Augello FR, Ciafarone A, Ciummo V, Altamura S, Cinque B, et al. 3D Models Currently Proposed to Investigate Human Skin Aging and Explore Preventive and Reparative Approaches: A Descriptive Review. Biomolecules. 2024; 14: 1066.

[70] Nicolaou A, Kendall AC. Bioactive lipids in the skin barrier mediate its functionality in health and disease. Pharmacol Ther. 2024; 260: 108681.

[71] Sanabria-de la TR, Montero-Vílchez T, García-Gavín J, Arias-Santiago S. Current Insights on Lipidomics in Dermatology: A Systematic Review. J Invest Dermatol. 2025; 145: 1105-16.e6.

[72] Roux E, Nicolas A, Valence F, Siekaniec G, Chuat V, Nicolas J, et al. The genomic basis of the Streptococcus thermophilus health-promoting properties . BMC Genomics. 2022; 23: 210.